Developing cell transplantation for temporal lobe epilepsy

R. Mark Richardson, Nicholas M. Barbaro, Arturo Alvarez-Buylla, Scott C. Baraban

Research output: Contribution to journalReview article

21 Scopus citations

Abstract

Mesial temporal lobe epilepsy (MTLE) is presumed to develop progressively as a consequence of synaptic reorganization and neuronal loss, although the exact etiology of seizure development is unknown. Nearly 30% of patients with MTLE have disabling seizures despite pharmacological treatment, and the majority of these patients are recommended for resection. The authors review cell transplantation as an alternative approach to the treatment of epilepsy. Recent work in animal models shows that grafted neuronal precursors that differentiate into inhibitory interneurons can increase the level of local inhibition. Grafts of these inhibitory neurons could help restore equilibrium in MTLE. Developing a sound transplantation strategy involves careful consideration of the etiology of MTLE and the expected functional role of transplanted cells. These issues are reviewed, with a focus on those factors most likely to influence clinically applicable results.

Original languageEnglish (US)
Article numberE16
JournalNeurosurgical focus
Volume24
Issue number3-4
DOIs
StatePublished - Mar 1 2008

Keywords

  • Epilepsy
  • Medial ganglionic eminence
  • Neural progenitor cell
  • Neurogenesis
  • Transplantation

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Developing cell transplantation for temporal lobe epilepsy'. Together they form a unique fingerprint.

  • Cite this

    Richardson, R. M., Barbaro, N. M., Alvarez-Buylla, A., & Baraban, S. C. (2008). Developing cell transplantation for temporal lobe epilepsy. Neurosurgical focus, 24(3-4), [E16]. https://doi.org/10.3171/FOC/2008/24/3-4/E15